Elife 11 Kaelberer MM et al (2018) A gut-brain neural circuit for nutrient sensory transduction
Health Canada confirmed it is reviewing eight other generic semaglutide submissions and expects further decisions in the coming weeks and months
The medications work by reducing appetite and improving satiety, making it easier to eat less, but patients who view them as solutions requiring zero behavior change typically experience less significant outcomes than trial data suggests
A majority of GLP-1 users feel like different people The survey found that 86% of GLP-1 users feel like a different person, with 47% describing the change as positive, and 9% as negative
Rapamycin addresses cellular senescence in the follicle microenvironment by inhibiting mTOR, while GHK-Cu works on Wnt signaling, inflammation, and androgen receptor sensitivity
Non-specific codes (e.g., F89 Unspecified developmental disorder) carry lower or no HHS-HCC weight compared to specific diagnoses